For over a century, errors in cell division that result in too few or too many chromosomes in daughter cells, a cytogenetic feature termed aneuploidy, have been described. Although a well-established feature of human cancer cells, it remains unclear whether acquired aneuploidy is a cause or consequence of tumorigenesis. Research into the molecular mechanisms of aneuploidy has focused largely on the role of mitosis and mitotic checkpoint signaling, primarily in cellular and animal models 1,2 . Recent human genomic studies have shown that aneuploidy can be estimated using intensity data from standard genotyping arrays, an approach that has been validated by DNA sequencing 3-5 . These population-based studies have demonstrated that mLOY is more frequent than other mosaic chromosomal and structural alterations; indeed, about one in five men over 80 years of age has detectable Y mosaicism in whole-blood-derived DNA 4 , which reflects the capacity of some cells to survive without this chromosome.
For over a century, errors in cell division that result in too few or too many chromosomes in daughter cells, a cytogenetic feature termed aneuploidy, have been described. Although a well-established feature of human cancer cells, it remains unclear whether acquired aneuploidy is a cause or consequence of tumorigenesis. Research into the molecular mechanisms of aneuploidy has focused largely on the role of mitosis and mitotic checkpoint signaling, primarily in cellular and animal models 1, 2 . Recent human genomic studies have shown that aneuploidy can be estimated using intensity data from standard genotyping arrays, an approach that has been validated by DNA sequencing [3] [4] [5] . These population-based studies have demonstrated that mLOY is more frequent than other mosaic chromosomal and structural alterations; indeed, about one in five men over 80 years of age has detectable Y mosaicism in whole-blood-derived DNA 4 , which reflects the capacity of some cells to survive without this chromosome.
Although mLOY is a common feature in the general population, whether it is relevant to disease susceptibility, or whether cells in tissues other than peripheral blood undergo similar rates of chromosomal loss, remains unclear. Population studies have identified correlations between mLOY and smoking status, an association that seems to be transient and reversible after smoking cessation 6 . Such epidemiological studies have also identified associations with nonhematological cancers 4, 5 and Alzheimer's disease 7 ; however, these observations are inconsistent 3 and possibly subject to confounding or reverse-causality.
The ability to assay a common measure of aneuploidy in large arraygenotyped populations could facilitate the systematic identification of variants and genes involved in cell division errors. This would, in turn, enable a better understanding of the mechanisms involved and of the potential causal consequences of aneuploidy on cancer risk, which may subsequently be inferred using Mendelian randomization approaches. To date, a single genetic association with mLOY near TCL1A has been reported (n = 12,369), suggesting that germline variation influencing mosaic chromosome loss can be detected 3 . Here we used data from up to 85,542 men to highlight widespread genomic, transcriptomic and epigenetic signatures of mosaic Y chromosome loss, and we demonstrate that this approach successfully identifies genes implicated in cell cycle regulation, genome instability and cancer susceptibility.
RESULTS
As a proxy for mLOY, we estimated the mean intensity log-R ratio of all array-genotyped Y chromosome single-nucleotide polymorphisms (SNPs) (which we refer to as mLRR-Y) in a sample of 67,034 male participants from the UK Biobank (UKB) cohort 8 . We observed a normal distribution that was centered around zero (s.d. = 0.067), with negative values indicating reduced Y chromosome abundance in the clonal blood cell population (Supplementary Fig. 1) .
Consistent with previous reports 3, 6 , we observed a strong negative correlation between mLRR-Y and age (r = −0.21) in the UKB discovery data. We also observed a strong association with 'ever smoking' status (P = 3.05 × 10 −82 ), which in combination with age explained 4.74% of the trait variance (age alone variance = 4.45%). We sought to demonstrate the causal relationship between smoking and mLOY through the principle of Mendelian randomization, using a reported and widely used genetic instrument for smoking frequency 9 . By modelling genetic variants at the CHRNA5-CHRNA3-CHRNB4 nicotinic receptor locus that are robustly associated with the number of cigarettes smoked per day, we inferred a causal effect of smoking on decreased mLRR-Y (increased Y chromosome loss) (rs1051730 P = 0.03; P never-smokers = 0.41, P ever-smokers = 0.04). This genetic association was confirmed in independent replication samples (European Prospective Investigation of Cancer (EPIC)-Norfolk cohort and the Icelandic deCODE cohort; combined n = 18,508, P = 0.009; overall combined P = 0.004).
Many autosomal genetic variants are associated with mLOY
To identify the genetic variants associated with mLOY, we performed a genome-wide association study (GWAS) of mLRR-Y as a quantitative trait in the UKB cohort. After stringent quality control (Online Methods), the most significantly associated SNPs were located at the previously reported 3 mLOY locus on chromosome 14, TCL1A (P = 3.6 × 10 −23 ) (Supplementary Fig. 2 ). In addition, we identified an additional 18 previously unknown signals at genome-wide significance (P < 5 × 10 −8 ), with no evidence for significant inflation of test statistics genome wide (λ = 1.05) ( Supplementary  Figs. 2 and 3) . We subsequently performed replication in an independent set of 9,793 men with array intensity data, and in a further 8,715 men from Iceland (deCODE cohort) with Y chromosome loss estimated using sequence reads (Online Methods). Both replication data sets provided strong statistical support for the identified loci, with all 19 loci retaining genome-wide significance in a combined model ( Table 1) . As evaluated in the deCODE cohort data, these loci cumulatively explained 2.7% of the total variance in Y chromosome copy number. We estimated an overall heritability of 34% (25.2-42.4%), suggesting that many additional associated variants remain to be discovered.
We next used HaploReg 10 and sequence data from the deCODE study to functionally annotate the variants and genes identified. This analysis highlighted four signals containing highly correlated missense variants, implicating MAD1L1 (rs1801368, r 2 > 0.98), PMF1 (rs1052053, r 2 = 1), NREP (rs11559, r 2 = 0.74) and NPAT (rs2070661, r 2 = 0.97) as potential candidates.
To ascertain whether the identified signals were more likely to reflect gain or loss of Y chromosome material, we performed two analyses comparing the bottom and top 5% of mLRR-Y-ranked individuals to the median 25%, as a dichotomous indicator of extreme Y chromosome loss or gain. All 19 loci showed consistently stronger associations with the bottom 5% of mLRR-Y (greatest mLOY) than with the top 5% (Supplementary Table 1 ), suggesting that their effect was on mosaic Y chromosome loss rather than its gain. Analysis of mLRR-Y as a continuous trait across all individuals was, however, the most powerful approach for variant discovery, as only two of the signals reached genome-wide significance in the stratified analysis. 
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Genome-wide pathway analyses conducted on association results for continuous mLRR-Y highlighted five pre-defined biological pathways that were enriched for association (study-wise significant false discovery rate (FDR) < 0.05), the most significant of which was 'apoptosis' as per the Kyoto Encyclopedia of Genes and Genomes (KEGG) 11 (Supplementary Table 2 ). Other pathways included sulfur metabolism, susceptibility to colorectal, prostate and thyroid cancers, and progesterone-mediated oocyte maturation.
The effect of mLOY variants on X-chromosome loss in women
We next sought to understand whether the variants we identified acted only on the Y chromosome or whether they promoted aneuploidy of other chromosomes more generally. Using a combined sample of 96,123 women from three studies, we ascertained X chromosome loss via both array-intensity data (n = 86,843) and sequence reads (n = 9,280) ( Fig. 1) . Chromosome X copy number was estimated to have a heritability of 26% (17.4-36.2%) in the deCODE data, which was comparable to that of Y chromosome loss. Cumulatively, the 19 mLOY SNPs significantly (P = 4 × 10 −6 ) predicted X chromosome loss in women, with the expected direction of effect (Fig. 2) .
Identification of transcriptomic and epigenetic signatures of mLOY
To identify potential functional transcripts that mediate Y chromosome loss, we applied summary statistic approaches to infer gene expression associations using three analytical imputation methods [12] [13] [14] in independent whole-blood expression data sets (Supplementary  Tables 3-5) . Across these data sets, eight genes (HM13, SMPD2, TCL1A, SENP7, NPAT, ATM, ACAT1 and CENPN) were significantly associated with mLRR-Y (α ≤ 0.05) after accounting for multiple testing (Online Methods), all of which mapped near to one of the 19 associated genetic signals from the GWAS.
We additionally identified 36 methylation variable positions (MVPs) that correlated with mLRR-Y levels in 569 whole-blood samples from the EPIC-Norfolk cohort 15 (Supplementary Table 6 ). All significant (P ≤ 1 × 10 −7 ) MVPs were in genomic regions that were distinct (>500 kb) from the 19 mLOY loci, with the exception of four correlated methylation probes within the TP53 gene region. To determine whether any of the methylation changes represented causal drivers of mLOY, we next identified cis-methylation quantitative trait loci (meQTLs) in publicly available data 16 for all of the associated probes. In total, 20 probes had one or more genetic variants in cis that were associated with methylation levels of the corresponding site (Supplementary Table 7 ). None of these genetic variants were correlated with the 19 genomic loci; however, one cis-meQTL survived multiple-test correction for association with mLRR-Y (rs7208523, cg20116579 methylation P = 5.6 × 10 −31 ; mLRR-Y P = 9 × 10 −4 ). This suggests that genetic variation at the TNK1 locus, a gene with known involvement in tumor growth and survival, may be associated with increased mLOY via an epigenetic mechanism 17 .
Genetic overlap with cancer susceptibility
Three mLOY signals are correlated with signals previously reported for basal cell carcinoma 18 , glioma 19 , neuroblastoma 20 (TP53) or testicular cancer 21, 22 (SEMA4A-PMF1 and MAD1L1). In each case, the mLRR-Y-decreasing allele (i.e., increased mLOY) was associated with increased cancer susceptibility. We performed a reciprocal lookup of 90 loci that were previously reported for prostate cancer susceptibility 23, 24 , the most common male non-skin cancer in western populations. There was no obvious enrichment of signal across these loci and no apparent dose-response relationship between the allelic effects on prostate cancer and mLOY (P EGGER-MR = 0.26; Supplementary Fig. 4 and Supplementary Table 8 ). Under the hypothesis that susceptibility to many types of cancer may have a common basis in mitotic error, we performed a GWAS in the UKB cohort, in which we defined men with any diagnosed cancer as a case (n = 7,745 cases; n = 58,562 controls). This approach was recently used for multiple reproductive cancers and yielded several novel loci 25 . We applied the 19 mLRR-Y signals as an additive genetic instrument but found no evidence of a dose-response relationship between genetically modeled mLOY and cancer risk in men (P EGGER-MR = 0.94; Supplementary Fig. 5 and Supplementary Table 9 ). To test the relationship between cancer risk and mLOY more comprehensively, we estimated the extent of shared genetic architecture across the whole genome using linkage disequilibrium (LD) score regression 26 . This analysis identified an overall significant inverse relationship between mLRR-Y and cancer risk (r g = −0.42, P = 0.02), which was not significant when we considered only female cancer cases (r g = −0.06, P = 0.64).
DISCUSSION
Our findings, together with those in previous reports, demonstrate that loss of the Y chromosome in peripheral blood likely represents a proxy trait for the study of aneuploidy in large-scale populations, which can be readily estimated from sequencing reads or array-based genotyping data. The nature of the genes identified by our analyses suggests that genetic determinants of mLOY reflect general mechanisms of aneuploidy, which we speculate most frequently manifest in mLOY owing to the higher capacity of cells to tolerate Y chromosome loss. This hypothesis is supported by the observation that these same SNPs also predicted X chromosome loss in women, the second most frequent large-scale mosaic event 27 . Pathway analyses identified enrichment for cancer and apoptosis pathways that were associated with mLOY. This is further supported by the many genes we observed that encode well-established cell cycle regulation factors, either as the closest gene to the association signal or implicated via altered expression or protein-coding changes. Major mechanistic aspects of the cell cycle and key regulators of cell cycle Figure 3 Overview of the involvement of mLOY-associated genes in the cell cycle. Genes falling within GWAS loci are shown in blue, and those implicated by methylation analyses in green. Grey boxes highlight specific checkpoints, signaling cascades or enzymes of note. Green arrows denote activation of a target by phosphorylation; blue arrows indicate a signaling cascade and its ultimate effect.
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progression were represented by these findings (Fig. 3) , including elements of three cell cycle checkpoints and several genes with complementary functional roles in mitosis. TPX2, CENPN, PMF1 and ATMIN are involved in aspects of chromosome alignment during metaphase, spindle assembly, orientation and attachment to chromatids ahead of segregation 28, 29 . In particular, TPX2 recruits the crucial mitotic enzyme, Aurora kinase A, to the spindle 30 , whereas ATMIN regulates expression of a dynein motor component (DYNLL1) that critically mediates spindle positioning [31] [32] [33] and also modulates Nek9 kinase signaling, which is required for correct spindle formation and function 34 . Similarly, Rho guanine-exchange factor 10 (encoded by ARHGEF10; for which we observed a nearby methylated signal) regulates centrosome duplication and prevents the formation of multipolar spindles 35 . We identified a missense-encoding variant in MAD1L1 (MAD1 mitotic arrest deficient like 1), a major component of the spindle assembly checkpoint. This checkpoint represents a key cellular safeguard against chromosome mis-segregation (and subsequent ploidy errors), as it suppresses metaphase-anaphase progression until the chromatids are bi-orientated on a bipolar spindle at the metaphase plate 1 . During cytokinesis, SEPT5 (septin 5; implicated in our methylation analysis) encodes a conserved cell cycle regulator that is required for effective cell division 36 , whereas activation of signaling by Rho guanine-exchange factor 10 (ARHGEF10) facilitates contractile ring ingression to separate the two daughter cells 37 .
We also implicated a number of genes with established roles in the replication and stability of nuclear DNA in interphase; replication errors are a key cause of genomic instability and chromosomal fragility [38] [39] [40] . G 1 -to-S-phase transition is dependent on NPAT, at least in part through its promotion of histone gene transcription 41 , whereas ATM, at least in part in association with ATMIN 42 , functions as major cell cycle checkpoint kinase that is dedicated to maintaining genome stability throughout interphase, with particular importance at the G 1 -S and G 2 -M checkpoints 40 . In response to double-stranded DNA breaks (DSBs), which are indicative of genomic instability, ATM promotes various responses via p53 and other factors to promote DNA repair, arrest cell cycle progression, or otherwise initiate cell cycle exit strategies, including apoptosis and senescence [38] [39] [40] 43 . TREX1 encodes 3′ repair exonuclease 1, which digests aberrant replication intermediates and single-stranded DNA arising from genotoxic stress, to prevent chronic checkpoint activation by these factors 44 . Predicted deleterious missense-encoding variants in this gene were recently identified in a mouse GWAS for micronucleus formation, a biomarker of chromosomal breaks, whole-chromosome loss and extranuclear DNA 45 .
At the later stages of the cellular lifespan, several genes implicated by our GWAS findings-including TP53, TCL1A, SMPD2, BCL2 and BCL2L1-functionally affect apoptotic events [46] [47] [48] [49] [50] . Apoptosis is a prime mechanism by which cells with detected DNA damage or ploidy errors may be eliminated 51 ; indeed, p53 drives multiple cell cycle exit responses in response to aberrant mitosis, including G 1 arrest 43, 52, 53 . The TP53 variant associated with mLOY in our analyses is the one that was previously associated with basal cell carcinoma risk: for this trait, the risk allele changes the AATAAA polyadenylation signal to AATACA, which results in impaired 3′-end processing of the TP53 mRNA 18 . Our findings also implicated genes involved in spermatogenesis 54, 55 (HENMT1 and DAZAP1) and in cellular growth and differentiation 56 
(DLK1).
The genes directly involved in mitotic prophase-metaphase and in the spindle assembly checkpoint have clear roles in averting chromosomal mis-segregation and preventing these from persisting unchecked; however, how the broader set of genes we identified here may function to promote mLOY remains less clear. We speculate that many of these genes act in ways that are not currently recognized or, alternatively, that the other highlighted processes outside of cell cycle control and mitosis are important. In particular, as a major mode of cell cycle exit, our observed enrichment of genes involved in apoptosis and its regulation may have a more passive permissive role in enabling mis-segregated cells to survive with ploidy errors rather than being directly causative of them.
Although an initial defect during the cell cycle process is required to generate an aneuploid daughter cell, clonal expansion is likely required to drive the lineage to a detectable frequency in the circulating white blood cell population. It is possible that mLOY in hematopoietic precursors confers a proliferative advantage to such cells, leading to a relative enrichment of assayable mLOY progeny. We therefore speculate that some loci may operate through this pathway to further facilitate or promote clonal expansion of these cells. Additional functional experimentation in cellular and animal systems is ultimately required to fully elucidate this issue and the role individual associated genes may have in promoting mLOY. We also acknowledge that there are likely other, currently unknown, mechanisms by which our associated loci exert their effects.
We observed a substantial shared genetic architecture between mLOY and cancer susceptibility, suggesting that bivariate analyses of these two traits may help to prioritize new cancer susceptibility loci and elucidate their functions. We could not, however, find evidence of a dose-response relationship between these two traits. This is perhaps not unexpected given that findings from mouse studies in which mitotic checkpoint components were experimentally downregulated demonstrate an inconsistent relationship between aneuploidy and spontaneous tumorigenesis 1 . It is possible, therefore, that some of the genes we identified may promote benign aneuploidy, whereas others may have a more general role in genome instability. This makes the use of genetic variants associated with mLOY difficult within a Mendelian randomization framework, as genes with general roles in instability may have different phenotypic consequences than genes that promote aneuploidy in a more stable way. This, of course, does not preclude the identification of causal risk factors for mLOY, which were exemplified by our positive causal inference for smoking on mLOY, using a genetic instrument for cigarettes per day. More generally, the association between smoking and mLOY suggests that care should be taken to avoid confounding influences, such as socioeconomic patterning, in epidemiological observations between mLOY and disease. In addition to fully evaluating the broader disease relevance of mLOY, future epidemiological studies should look to assess the differential rates at which mLOY changes in individuals over time, its relevance in other tissue types and further nongenetic modifiable factors that may influence it.
In conclusion, our study highlights that estimation of mLOY, using genotype-array-intensity data may serve as a useful quantitative measure of cell cycle efficiency and genome stability, and it may thereby add a new approach to the study of cellular aging and its associations with disease, particularly cancer.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
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We thank members of the MRC Epidemiology Unit genetics group for useful Friday morning discussions. This research was conducted using the UK Biobank Resource genome-wide SNP data and then regresses the imputed transcriptome levels with the phenotype of interest. MetaXcan extends its application to allow inference of the direction and magnitude of GPGE-phenotype associations with only summary GWAS statistics, which is advantageous when SNP-phenotype associations result from a meta-analysis setting, and also when individuallevel data are not available. As input, we used GWAS meta-analysis summary statistics for mLRR-Y, LD matrix from the 1000 Genomes project, and, as weights, gene expression regression coefficients for SNPs from models trained with whole-blood transcriptomic data from the GTEx Project 63 . The threshold for statistical significance was estimated using the Bonferroni correction for the number of tested genes.
Finally, we used the recently described TWAS approach 12 to infer gene expression association using two whole-blood data sets (Young Finns Study and The Netherlands Twin Registry cohorts). The threshold for significance was set to correct for the number of studies and genes (P < 1 × 10 −5 ). Each of the three approaches described in this section was compared by estimating the correlation (r) of association z-scores across genes present in all three data sets. There was strong concordance between the 2,326 transcripts analyzed across the three approaches and data sets: SMR versus TWAS, r = 0.72; SMR versus MetaXcan, r = 0.54; TWAS versus MetaXcan, r = 0.55.
Methylation. DNA methylation in whole blood was measured for 1,378 individuals in the EPIC-Norfolk cohort using the Illumina Human Methylation 450k BeadChip platform. After setting methylation markers with detection P ≥ 0.01 to 'missing' , methylation β-values were calculated for each marker. Quantile normalization of methylation β-values was applied separately to different marker groups based on color channel, probe type and methylated/ unmethylated intensity (M/U) subtype of probes (type-I M red, type-I U red, type-I M green, type-I U green, type-II red, type-II green) 64 . Samples with a sample call rate ≤0.99 were removed (n = 77). Methylation β-value distributions of the X, Y and autosomal chromosome markers were analyzed separately, and a further 11 sample outliers were excluded. Within each sample, markers with a marker call rate ≤0.95 were excluded (n = 4,423).
All further downstream analyses were restricted to autosomal methylation markers. Signal detection of methylation intensities can be affected by several factors, including SNPs on the probe, repetitive DNA and cross-reactive probes. We thus calculated the proportion of missing data at each CpG site (marker call rate), and 8,775 CpGs with a call rate ≤0.95 were excluded. 3,295 CpGs with multimodal distributions of methylation intensities that were identified by the R package ENmix 65 , which typically arise from technical artifacts, were also excluded. A further 18,874 CpG sites that were previously identified as mapping to more than one genomic location 66 were also excluded. The final cleaned data set comprised 442,920 autosomal CpG sites. To account for cell composition variability, we estimated counts of T lymphocyte subtypes, natural killer cells, monocytes, granulocytes and B lymphocytes using the minfi R package 67, 68 . These were included as covariates in subsequent epigenomewide regression models.
To examine the association between methylation markers and mLOY, we performed an epigenome-wide association analysis in all male EPIC-Norfolk methylation samples (n = 569). mLRR-Y was regressed separately on each methylation marker, adjusted for type 2 diabetes status, age, current smoking status, estimated cell counts and sample plate. Bonferroni correction was applied, accounting for the number of markers tested (P = 1 × 10 −7 ). Furthermore, we checked that no significant CpG sites had sequences that also mapped to the Y chromosome.
Association statistics for genetic variants within the probe vicinity and corresponding methylation levels (i.e., cis-meQTLs) were available from the BIOS QTL browser (http://www.genenetwork.nl/biosqtlbrowser/).
Pathway analyses. Meta-analysis gene set enrichment of variant associations (MAGENTA) was used to explore pathway-based associations in the full GWAS data set. MAGENTA implements a gene set enrichment analysis (GSEA)-based approach, as previously described 69 . Briefly, each gene in the genome is mapped to a single index SNP with the lowest P value within a 110-kb upstream and 40-kb downstream window. This P value, which represents a gene score, is then corrected for confounding factors such as gene size, SNP density and LD-related properties in a regression model. Genes within the HLA region were excluded from analysis due to difficulties in accounting for gene density and LD patterns. Each mapped gene in the genome is then ranked by its adjusted gene score. At a given significance threshold (95th and 75th percentiles of all gene scores), the observed number of gene scores in a given pathway, with a ranked score above the specified threshold percentile, is calculated. This observed statistic is then compared to 1,000,000 randomly permutated pathways of identical size. This generates an empirical GSEA P value for each pathway. Study-wise significance was determined when an individual pathway reached a FDR <0.05 in either analysis. In total, 3,216 pathways from Gene Ontology, PANTHER, KEGG and Ingenuity were tested for enrichment of multiple modest associations with mLRR-Y.
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